Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, we, as a Congress, have worked over the past several years to combat the opioid epidemic and support the millions of Americans with a substance use disorder. That work…

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I just want to say that I appreciate my colleagues who have come to the floor to speak on this bill. I think everyone knows that this is a very personal issue for me, not…

Mr. Speaker, we do not have any more speakers, and I am prepared to close if my Republican colleagues don't have any more speakers. Mr. Speaker, I reserve the balance of my time.

Mr. Speaker, I yield an additional 30 seconds to the gentlewoman from Texas (Ms. Jackson Lee).

Mr. Speaker, I thank the gentlewoman for her comments, and I look forward to our work together going forward. Mr. Speaker, I reserve the balance of my time.

Mr. Speaker, I yield myself such time as I may consume. I thank the gentlewoman for those comments, and I echo the need to address mandatory minimum sentencing and comprehensive criminal justice reform. The opioid epidemic is not a problem…

So, you think overall that would be beneficial for Americans, including vulnerable populations and those that are receiving their medically-assisted treatment, that this will improve access----

Thank you. And how is the legislation before us today effective in closing the loophole that has prevented other companies from entering the market with new formulations?

How might the entrance of new formulations of buprenorphine improve treatment in vulnerable populations?

In my view, passing H.R. 4712 is a common sense step that will be good for orphan drug policy, good for public health, and good for the millions of Americans with opioid use disorder.

I have introduced legislation that we call the Humane Correctional Health Care Act and what this would do is continue Medicaid coverage during incarceration.